🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Design Therapeutics, Inc.

Design Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

Gene TAC

Design Therapeutics, Inc. is a preclinical-stage biopharmaceutical company developing therapies for genetic diseases caused by nucleotide repeat expansions. Their portfolio includes products targeting Friedreich Ataxia and Myotonic Dystrophy Type-1, as well as Gene TAC candidates for other similar diseases.

Tags: Friedreich Ataxia, Gene TAC, Myotonic Dystrophy Type-1, biopharmaceutical, genetic diseases, nucleotide repeat expansions, preclinical-stage, therapy development

Website

About | Contact | Careers | About | About | About | About | About | News | About | Careers | About

Symbol: DSGN

Recent Price: $6.17

Industry: Biotechnology

CEO: Mr. Pratik Shah Ph.D.

Sector: Healthcare

Employees: 57

Address: 6005 Hidden Valley Road, Carlsbad, CA 92011

Phone: 858 293 4900

Last updated: 2024-12-31